Soluble CD14 in periodontitis

Innate Immunity

Volumn 15, Issue 2, 2009, Pages 121-128

  Nicu, Elena A ^a   Laine, Marja L ^a   Morré, Servaas A ^b,c   Van der Velden, Ubele ^a   Loos, Bruno G ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aggregatibacter actinomycetemcomitans; CD14 260 genotype; CRP; Inflammation; Periodontitis; sCD14

Indexed keywords

BACTERIUM ANTIBODY; C REACTIVE PROTEIN; CD14 ANTIGEN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN G; LOW DENSITY LIPOPROTEIN;

ADULT; AGE DISTRIBUTION; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; EDUCATIONAL STATUS; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; FEMALE; GENOTYPE; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PROTEIN BLOOD LEVEL;

ACTINOMYCETACEAE; ACTINOMYCETALES INFECTIONS; ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ANTIGENS, CD14; BACTEROIDACEAE INFECTIONS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PERIODONTITIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PORPHYROMONAS GINGIVALIS; PROGNOSIS; RISK FACTORS; TOOTH LOSS;

PORPHYROMONAS GINGIVALIS;

EID: 63349103273     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425908101577     Document Type: Article

References (33)

1. Maliszewski CR CD14 and immune response to lipopolysaccharide. Science 1991; 252: 1321-1322.
2. Ziegler-Heitbrock HW, Ulevitch RJ CD14: Cell surface receptor and differentiation marker. Immunol Today 1993; 14: 121-125.
3. Liuzzo G., Angiolillo DJ, Buffon A. et al. Enhanced response of blood monocytes to in vitro lipopolysaccharide-challenge in patients with recurrent unstable angina. Circulation 2001; 103: 2236-2241.
4. Bas S., Gauthier BR, Spenato U., Stingelin S., Gabay C. CD14 is an acute-phase protein. J Immunol 2004; 172: 4470-4479.
5. Feingold KR, Funk JL, Moser AH, Shigenaga JK, Rapp JH, Grunfeld C. Role for circulating lipoproteins in protection from endotoxin toxicity. Infect Immun 1995; 63: 2041-2046.
6. Pussinen PJ, Tuomisto K., Jousilahti P., Havulinna AS, Sundvall J., Salomaa V. Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol 2007; 27: 1433-1439.
7. Hayashi J., Masaka T., Ishikawa I. Increased levels of soluble CD14 in sera of periodontitis patients. Infect Immun 1999; 67: 417-420.
8. Forner L., Larsen T., Kilian M., Holmstrup P. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol 2006; 33: 401-407.
9. Hansson GK, Robertson AK, Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev Pathol 2006; 1: 297-329.
10. Anderson JL, Carlquist JF, Muhlestein JB, Horne BD, Elmer SP Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 1998; 32: 35-41.
11. Janket SJ, Baird AE, Chuang SK, Jones JA Meta-analysis of periodontal disease and risk of coronary heart disease and stroke. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 559-569.
12. Paraskevas S., Huizinga JD, Loos BG A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008; 35: 277-290.
13. Baldini M., Lohman IC, Halonen M., Erickson RP, Holt PG, Martinez FD A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999; 20: 976-983.
14. Hubacek JA, Pit'ha J., Skodova Z., Poledne R. C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 1999; 99: 3218-3220.
15. Rupp J., Goepel W., Kramme E., Jahn J., Solbach W., Maass M. CD14 promoter polymorphism -159C>T is associated with susceptibility to chronic Chlamydia pneumoniae infection in peripheral blood monocytes. Genes Immun 2004; 5: 435-438.
16. Laine ML, Morre SA, Murillo LS, van Winkelhoff AJ, Pena AS CD14 and TLR4 gene polymorphisms in adult periodontitis. J Dent Res 2005; 84: 1042-1046.
17. Bizzarro S., van der Velden U., ten Heggeler JM et al. Periodontitis is characterized by elevated PAI-1 activity. J Clin Periodontol 2007; 34: 574-580.
18. Nicu EA, van der Velden U., Everts V., Loos BG Expression of FcgammaRs and mCD14 on polymorphonuclear neutrophils and monocytes may determine periodontal infection. Clin Exp Immunol 2008; 154: 177-186.
19. Friedewald WT, Levy RI, Fredrickson DS Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
20. Pussinen PJ, Vilkuna-Rautiainen T., Alfthan G., Mattila K., Asikainen S. Multiserotype enzyme-linked immunosorbent assay as a diagnostic aid for periodontitis in large-scale studies. J Clin Microbiol 2002; 40: 512-518.
21. Takeshita S., Nakatani K., Tsujimoto H., Kawamura Y., Kawase H., Sekine I. Increased levels of circulating soluble CD14 in Kawasaki disease. Clin Exp Immunol 2000; 119: 376-381.
22. Wuthrich B., Kagi MK, Joller-Jemelka H. Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis. Arch Dermatol Res 1992; 284: 339-342.
23. Oesterreicher C., Pfeffel F., Petermann D., Muller C. Increased in vitro production and serum levels of the soluble lipopolysaccharide receptor sCD14 in liver disease. J Hepatol 1995; 23: 396-402.
24. Horneff G., Sack U., Kalden JR, Emmrich F., Burmester GR Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis. Clin Exp Immunol 1993; 91: 207-213.
25. Egerer K., Feist E., Rohr U., Pruss A., Burmester GR, Dorner T. Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus. Lupus 2000; 9: 614-621.
26. Kruger C., Schutt C., Obertacke U. et al. Serum CD14 levels in polytraumatized and severely burned patients. Clin Exp Immunol 1991; 85: 297-301.
27. Bas S., Gauthier BR, Spenato U., Stingelin S., Gabay C. CD14 is an acute-phase protein. J Immunol 2004; 172: 4470-4479.
28. Kallio KA, Buhlin K., Jauhiainen M. et al. Lipopolysaccharide associates with pro-atherogenic lipoproteins in periodontitis patients. Innate Immun 2008; 14: 247-253.
29. Kitchens RL, Thompson PA, Viriyakosol S., O'Keefe GE, Munford RS Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins. J Clin Invest 2001; 108: 485-493.
30. Lakio L., Lehto M., Tuomainen AM et al. Pro-atherogenic properties of lipopolysaccharide from the periodontal pathogen Actinobacillus actinomycetemcomitans. J Endotoxin Res 2006; 12: 57-64.
31. Hettne KM, Weeber M., Laine ML et al. Automatic mining of the literature to generate new hypotheses for the possible link between periodontitis and atherosclerosis: Lipopolysaccharide as a case study. J Clin Periodontol 2007; 34: 1016-1024.
32. Eng HL, Wang CH, Chen CH, Chou MH, Cheng CT, Lin TM A CD14 promoter polymorphism is associated with CD14 expression and Chlamydia-stimulated TNF alpha production. Genes Immun 2004; 5: 426-430.
33. Koenig W., Khuseyinova N., Hoffmann MM et al. CD14 C(-260)→T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease. J Am Coll Cardiol 2002; 40: 34-42.